Ortin Global Limited (BOM:539287)

India flag India · Delayed Price · Currency is INR
15.22
0.00 (0.00%)
At close: Apr 28, 2026
42.11%
Market Cap 117.91M
Revenue (ttm) 1.12M
Net Income (ttm) -8.95M
Shares Out 8.13M
EPS (ttm) -1.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Average Volume 1,000
Open 15.22
Previous Close 15.22
Day's Range 15.22 - 15.22
52-Week Range 10.15 - 19.15
Beta 0.55
RSI 44.81
Earnings Date May 29, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 3
Stock Exchange Bombay Stock Exchange
Ticker Symbol 539287
Full Company Profile

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.

Financial Statements

News

There is no news available yet.